Massachusetts General Hospital to Study How Psychedelics Influence the Brain
Massachusetts General Hospital is partnering with Atai Life Sciences to study the effects of psychedelics on the human brain. Atai Life Sciences is a biotech firm focused on developing medications to manage schizophrenia while also working on creating alternative treatments for various mental health conditions such as anxiety and depression. The two organizations decided to work together after the hospital set up a program, named the Center for Neuroscience of Psychedelics, to study psychedelic therapy. A psychiatric at the hospital, Jerrold Rosenbaum is the head of the program and has specialized in the treatment of psychiatric disorders. Rosenbaum stated that…